HDM1002 200 mg

DRUG4 trials

Sponsors

Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.

Conditions

Healthy Adult SubjectType 2 Diabetes

Phase 1

A Study of HDM1002 Tablets on Cardiac Repolarization in Healthy Subjects

RecruitingNCT07594847

Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.Healthy Adult Subject

Start: 2026-03-07End: 2026-11-06Target: 72Updated: 2026-05-19

Phase 2

To Evaluate Efficacy and Safety of HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus

CompletedNCT06481085

Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.Type 2 Diabetes

Start: 2024-06-27End: 2025-06-30Updated: 2025-07-28

Phase 3

A Phase 3 Study to Evaluate Efficacy and Safety of HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus

RecruitingNCT07082114

Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.Type 2 Diabetes

Start: 2025-07-14End: 2027-05-17Target: 800Updated: 2025-07-24

Study to Evaluate HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus

RecruitingNCT07193459

Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.Type 2 Diabetes

Start: 2025-08-12End: 2027-02-01Target: 360Updated: 2025-09-25